PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Brimonidine tartrate - Glaucoma / ocular hypertension
PAD Profile : Brimonidine tartrate - Glaucoma / ocular hypertension Important
Keywords :
Intra-ocular pressure
Brand Names Include :
Alphagan
Important Information :
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Latanoprost
- Bimatoprost
- Timolol
- Dorzolamide and timolol
- Brinzolamide
- Dorzolamide
- Latanoprost and timolol
- Acetazolamide
- Timolol and bimatoprost
- Timolol and brimonidine
- Brinzolamide/brimonidine
- Brinzolamide and timolol
- Tafluprost
- Travoprost
- Timolol and travoprost
- Pilocarpine hydrochloride
- Betaxolol
- Levobunolol hydrochloride
- Apraclonidine
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
22 July 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.
Note; the branded product (Alphagan) was considered BLACK at the PCN in May 2017.
Associated BNF Codes
11. Eye
11.06.00. Treatment of glaucoma